Adma Biologics Stock Investor Sentiment
| ADMA Stock | USD 21.18 0.12 0.56% |
About 57% of ADMA Biologics' investor base is looking to short. The analysis of the overall investor sentiment regarding ADMA Biologics suggests that many traders are alarmed. The current market sentiment, together with ADMA Biologics' historical and current headlines, can help investors time the market. In addition, many technical investors use ADMA Biologics stock news signals to limit their universe of possible portfolio assets.
ADMA |
ADMA Biologics Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards ADMA Biologics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Far too much social signal, news, headlines, and media speculation about ADMA Biologics that are available to investors today. That information is available publicly through ADMA media outlets and privately through word of mouth or via ADMA internal channels. However, regardless of the origin, that massive amount of ADMA data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of ADMA Biologics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of ADMA Biologics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to ADMA Biologics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive ADMA Biologics alpha.
ADMA Biologics Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Disposition of 24150 shares by Kestenberg-messina Kaitlin M. of ADMA Biologics at 16.8965 subject to Rule 16b-3 | 09/27/2024 |
2 | Acquisition by Adam Grossman of 870950 shares of ADMA Biologics at 5.4 subject to Rule 16b-3 | 10/04/2024 |
3 | Wall Street Bulls Look Optimistic About Adma Biologics Should You Buy | 10/30/2024 |
4 | ADMA Biologics Q3 2024 Earnings Preview | 11/06/2024 |
5 | Recent Price Trend in Adma Biologics is Your Friend, Heres Why | 11/11/2024 |
6 | The Schall Law Firm Invites Shareholders To Join An Inquiry Into ADMA Biologics Inc For Securities Law Violations | 11/13/2024 |
7 | AWM Investment Company, Inc. Acquires New Stake in Burcon NutraScience Corp | 11/15/2024 |
8 | Wall Street Analysts See a 31.3 percent Upside in Adma Biologics Can the Stock Really Move This High | 11/18/2024 |
9 | ADMA Biologics shares retain Outperform rating on performance | 11/19/2024 |
10 | The Schall Law Firm Encourages Shareholders To Take Part In An Inquiry Into ADMA Biologics Inc For Securities Law Violations | 11/21/2024 |
11 | Disposition of 48967 shares by Adam Grossman of ADMA Biologics at 21.1 subject to Rule 16b-3 | 11/22/2024 |
Complementary Tools for ADMA Stock analysis
When running ADMA Biologics' price analysis, check to measure ADMA Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ADMA Biologics is operating at the current time. Most of ADMA Biologics' value examination focuses on studying past and present price action to predict the probability of ADMA Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ADMA Biologics' price. Additionally, you may evaluate how the addition of ADMA Biologics to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |